|   | [x] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|--------|----------------------------------------------------------------------------------------------|

|   | [  ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|--------|----------------------------------------------------------------------------------------------------------|

| Delaware                                                       | 06-1150326                        |
|----------------------------------------------------------------|-----------------------------------|
|                                                           |                              |
| (State or other jurisdiction of incorporation or organization) | (IRS employer identification no.) |

| Two Manhattanville Road                  |       |
|------------------------------------------|------------|
| Purchase, NY                             | 10577      |
|                                     |       |
| (Address of principal executive offices) | (Zip code) |

| Large Accelerated filer   ̈ | Accelerated Filer  x              |
|-------------------------------------------|---------------------------------------------|
|                                      |                                        |
| Non-Accelerated filer   ̈   | Smaller Reporting Company   ̈ |

----

|                                                                                                                   |     |                                                                                                         | Page   |
|------------------------------------------------------------------------------------------------------------------------|----------|--------------------------------------------------------------------------------------------------------------|--------|
| PART I.                                                                                                                |     | FINANCIAL INFORMATION                                                                                        |   |
|                                                                                                                   |     |                                                                                                         |   |
| Item 1.                                                                                                                |     | Financial Statements                                                                                         |   |
|                                                                                                                   |     |                                                                                                         |   |
|                                                                                                                   |     |                                                                                                         |   |
|                                                                                                                   |     | Consolidated Balance Sheets at September 30, 2010 and December 31, 2009                                      | 3      |
|                                                                                                                   |     |                                                                                                         |   |
|                                                                                                                   |     | Consolidated Statements of Operations for the three and nine-month periods ended September 30, 2010 and 2009 | 4      |
|                                                                                                                   |     |                                                                                                         |   |
|                                                                                                                   |     | Consolidated Statements of Shareholders’ Equity for the nine-month period ended September 30, 2010     | 5      |
|                                                                                                                   |     |                                                                                                         |   |
|                                                                                                                   |     | Consolidated Statements of Cash Flows for the three and nine-month periods ended September 30, 2010 and 2009 | 6      |
|                                                                                                                   |     |                                                                                                         |   |
|                                                                                                                   |     | Notes to Consolidated Financial Statements                                                                   | 7-17   |
|                                                                                                                   |     |                                                                                                         |   |
|                                                                                                                   |     |                                                                                                         |   |
| Item 2.                                                                                                                |     | Management’s Discussion and Analysis of Financial Condition and Results of Operations                  | 18-28  |
|                                                                                                                   |     |                                                                                                         |   |
| Item 3.                                                                                                                |     | Quantitative and Qualitative Disclosures About Market Risk                                                   | 28     |
|                                                                                                                   |     |                                                                                                         |   |
| Item 4.                                                                                                                |     | Controls and Procedures                                                                                      | 29     |
|                                                                                                                   |     |                                                                                                         |   |
| PART II.                                                                                                               |     | OTHER INFORMATION                                                                                            |   |
|                                                                                                                   |     |                                                                                                         |   |
| Item 1.                                                                                                                |     | Legal Proceedings                                                                                            | 30     |
|                                                                                                                   |     |                                                                                                         |   |
| Item 1A.                                                                                                               |     | Risk Factors                                                                                                 | 30     |
|                                                                                                                   |     |                                                                                                         |   |
| Item 2.                                                                                                                |     | Unregistered Sales of Equity Securities and Use of Proceeds                                                  | 30     |
|                                                                                                                   |     |                                                                                                         |   |
| Item 3.                                                                                                                |     | Defaults Upon Senior Securities                                                                              | 30     |
|                                                                                                                   |     |                                                                                                         |   |
| Item 4.                                                                                                                |     | (Removed and Reserved)                                                                                       | 30     |
|                                                                                                                   |     |                                                                                                         |   |
| Item 5.                                                                                                                |     | Other Information                                                                                            | 30     |
|  Item 6.                                                                                                          |     |  Exhibits                                                                                               | 30     |
|                                                                                                                   |     |                                                                                                         |   |
| SIGNATURES                                                                                                             | 31       |
|                                                                                                                   |     |                                                                                                         |   |
| CERTIFICATIONS PURSUANT TO RULE 13A-14(A), AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002        | EXHIBITS |
|                                                                                                                   |     |                                                                                                         |   |
| CERTIFICATIONS PURSUANT TO 18 U.S.C. § 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 | EXHIBITS |

----

|                                                                                                                                                                                                                                     | September 30, |          | December 31, |    |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------|---------------|--------------|---------|
|                                                                                                                                                                                                                                     |          | 2010          |         |    | 2009 |   |
|                                                                                                                                                                                                                                     |          | (unaudited)   |         |    |   |   |
| ASSETS                                                                                                                                                                                                                                   |          |          |         |    |   |   |
| Current Assets:                                                                                                                                                                                                                          |          |          |         |    |   |   |
| Cash and cash equivalents                                                                                                                                                                                                                | $             | 52,173        |         | $       | 28,865 |   |
| Patient and other receivables, net                                                                                                                                                                                                       |          | 7,404         |         |    | 6,964 |   |
| Deferred taxes                                                                                                                                                                                                                           |          | 2,969         |         |    | 2,883 |   |
| Other current assets                                                                                                                                                                                                                     |          | 9,590         |         |    | 7,653 |   |
| Total current assets                                                                                                                                                                                                                     |          | 72,136        |         |    | 46,365 |   |
|                                                                                                                                                                                                                                     |          |          |         |    |   |   |
| Fixed assets, net                                                                                                                                                                                                                        |          | 17,122        |         |    | 16,705 |   |
| Intangible assets, Business Service Rights, net                                                                                                                                                                                          |          | 23,239        |         |    | 24,210 |   |
| Goodwill                                                                                                                                                                                                                                 |          | 30,334        |         |    | 30,334 |   |
| Trade names and trademarks                                                                                                                                                                                                               |          | 4,442         |         |    | 4,442 |   |
| Other assets                                                                                                                                                                                                                             |          | 1,825         |         |    | 2,253 |   |
| Total assets                                                                                                                                                                                                                             |  $       |  149,098 |         |  $ |  124,309 |   |
|                                                                                                                                                                                                                                     |          |          |         |    |   |   |
| LIABILITIES AND SHAREHOLDERS’ EQUITY                                                                                                                                                                                               |          |          |         |    |   |   |
| Current liabilities:                                                                                                                                                                                                                     |          |          |         |    |   |   |
| Accounts payable                                                                                                                                                                                                                         | $             | 2,839         |         | $       | 2,846 |   |
| Accrued liabilities                                                                                                                                                                                                                      |          | 17,353        |         |    | 15,119 |   |
| Current portion of long-term notes payable and other obligations                                                                                                                                                                         |          | 3,791         |         |    | 11,317 |   |
| Due to Fertility Medical Practices                                                                                                                                                                                                       |          | 12,442        |         |    | 6,424 |   |
| Attain IVF deferred revenue and other patient deposits                                                                                                                                                                                   |          | 16,585        |         |    | 13,362 |   |
| Total current liabilities                                                                                                                                                                                                                |          | 53,010        |         |    | 49,068 |   |
|                                                                                                                                                                                                                                     |          |          |         |    |   |   |
| Deferred and other tax liabilities                                                                                                                                                                                                       |          | 2,177         |         |    | 2,199 |   |
| Long-term notes payable and other obligations                                                                                                                                                                                            |          | 11,858        |         |    | 14,849 |   |
| Total liabilities                                                                                                                                                                                                                        |          | 67,045        |         |    | 66,116 |   |
|                                                                                                                                                                                                                                     |          |          |         |    |   |   |
| Commitments and Contingencies                                                                                                                                                                                                            |          |          |         |    |   |   |
|                                                                                                                                                                                                                                     |          |          |         |    |   |   |
| Shareholders’ equity:                                                                                                                                                                                                              |          |          |         |    |   |   |
| Common Stock, $.01 par value – 20,000,000 shares authorized at September 30, 2010 and 15,000,000 at December 31, 2009,  11,731,183 and 8,831,558 shares issued at September 30, 2010 and December 31, 2009, respectively |          | 117           |         |    | 88 |   |
| Capital in excess of par                                                                                                                                                                                                                 |          | 75,933        |         |    | 56,354 |   |
| Other comprehensive loss                                                                                                                                                                                                                 |          | (82)          |         |    | (188 | ) |
| Treasury stock, at cost – 6,848 and 46,408 shares at September 30, 2010 and December 31, 2009, respectively                                                                                                                        |          | (64)          |         |    | (375 | ) |
| Retained earnings                                                                                                                                                                                                                        |          | 6,149         |         |    | 2,314 |   |
| Total shareholders’ equity                                                                                                                                                                                                         |          | 82,053        |         |    | 58,193 |   |
| Total liabilities and shareholders’ equity                                                                                                                                                                                         |  $       |  149,098 |         |  $ |  124,309 |   |

----

|                                                     |   | For theThree-month periodEnded September 30, |   |   | For theNine-month periodEnded September 30, |   |
|----------------------------------------------------------|--------|----------------------------------------------|--------|--------|---------------------------------------------|--------|
|                                                     |   | 2010                                         |   |   | 2009                                        |   |   | 2010 |   |   | 2009 |   |
| Revenues, net                                            |   |                                         |   |   |                                        |   |   |   |   |   |   |   |
| Attain Fertility Centers                                 |   | $                                            | 45,899 |   |                                        | $      | 40,977 |   |   | $ | 135,523 |   |   | $ | 124,780 |   |
| Vein Clinics                                             |   |                                         | 14,658 |   |                                        |   | 12,621 |   |   |   | 43,826 |   |   |   | 37,288 |   |
|  Total revenues                                     |   |                                         | 60,557 |   |                                        |   | 53,598 |   |   |   | 179,349 |   |   |   | 162,068 |   |
|                                                     |   |                                         |   |   |                                        |   |   |   |   |   |   |   |   |   |   |   |
| Costs of services and sales                              |   |                                         |   |   |                                        |   |   |   |   |   |   |   |   |   |   |   |
| Attain Fertility Centers                                 |   |                                         | 41,263 |   |                                        |   | 36,930 |   |   |   | 122,053 |   |   |   | 112,361 |   |
| Vein Clinics                                             |   |                                         | 14,546 |   |                                        |   | 11,626 |   |   |   | 40,891 |   |   |   | 34,257 |   |
| Total costs of services and sales                        |   |                                         | 55,809 |   |                                        |   | 48,556 |   |   |   | 162,944 |   |   |   | 146,618 |   |
|                                                     |   |                                         |   |   |                                        |   |   |   |   |   |   |   |   |   |   |   |
| Contribution                                             |   |                                         |   |   |                                        |   |   |   |   |   |   |   |   |   |   |   |
| Attain Fertility Centers                                 |   |                                         | 4,636  |   |                                        |   | 4,047 |   |   |   | 13,470 |   |   |   | 12,419 |   |
| Vein Clinics                                             |   |                                         | 112    |   |                                        |   | 995 |   |   |   | 2,935 |   |   |   | 3,031 |   |
| Total contribution                                       |   |                                         | 4,748  |   |                                        |   | 5,042 |   |   |   | 16,405 |   |   |   | 15,450 |   |
|                                                     |   |                                         |   |   |                                        |   |   |   |   |   |   |   |   |   |   |   |
| General and administrative expenses                      |   |                                         | 2,961  |   |                                        |   | 2,764 |   |   |   | 9,403 |   |   |   | 9,333 |   |
| Interest income                                          |   |                                         | (33    | )      |                                        |   | (44 | ) |   |   | (103 | ) |   |   | (187 | ) |
| Interest expense                                         |   |                                         | 192    |   |                                        |   | 303 |   |   |   | 685 |   |   |   | 869 |   |
| Total other expenses                                     |   |                                         | 3,120  |   |                                        |   | 3,023 |   |   |   | 9,985 |   |   |   | 10,015 |   |
|                                                     |   |                                         |   |   |                                        |   |   |   |   |   |   |   |   |   |   |   |
| Income before income taxes                               |   |                                         | 1,628  |   |                                        |   | 2,019 |   |   |   | 6,420 |   |   |   | 5,435 |   |
| Income tax provision                                     |   |                                         | 529    |   |                                        |   | 791 |   |   |   | 2,585 |   |   |   | 2,173 |   |
| Net income                                               |   | $                                            | 1,099  |   |                                        | $      | 1,228 |   |   | $ | 3,835 |   |   | $ | 3,262 |   |
|                                                     |   |                                         |   |   |                                        |   |   |   |   |   |   |   |   |   |   |   |
| Basic and diluted net earnings per share of Common Stock |   |                                         |   |   |                                        |   |   |   |   |   |   |   |   |   |   |   |
| Basic earnings per share                                 |   | $                                            | 0.09   |   |                                        | $      | 0.14 |   |   | $ | 0.34 |   |   | $ | 0.37 |   |
| Diluted earnings per share                               |   | $                                            | 0.09   |   |                                        | $      | 0.14 |   |   | $ | 0.34 |   |   | $ | 0.37 |   |
|                                                     |   |                                         |   |   |                                        |   |   |   |   |   |   |   |   |   |   |   |
| Weighted average shares – basic                    |   |                                         | 11,718 |   |                                        |   | 8,776 |   |   |   | 11,264 |   |   |   | 8,770 |   |
| Weighted average shares - diluted                        |   |                                         | 11,771 |   |                                        |   | 8,839 |   |   |   | 11,314 |   |   |   | 8,833 |   |

----

|                                                         |   | Common Stock |    |   |   |   |    |                    |   |   | Treasury Shares                         |   |   |   |    |   |   |   |
|--------------------------------------------------------------|--------|--------------|---------|--------|--------|--------|---------|-------------------------|--------|--------|-----------------------------------------|--------|--------|--------|---------|--------|--------|--------|
|                                                         |   | Shares       |    |   | Amount |   |    | Capital inExcess of Par |   |   | Accumulated Comprehensive Income (loss) |   |   | Shares |    |   | Amount |   |   | Retained Earnings |   |   | Total Equity |   |
| Balance at December 31, 2009                                 |   |         | 8,832   |   |   | $      | 88      |                    |   | $      | 56,354                                  |   |   | $      | (188    | )      |   |   | (46 | ) |   | $ | (375 | ) |   | $ | 2,314 |   |   | $ | 58,193 |   |
| Stock awards granted, net                                    |   |         | 168     |   |   |   | 2       |                    |   |   | 2                                       |   |   |   | — |   |   |   | (45 | ) |   |   | (346 | ) |   |   | — |   |   |   | (342 | ) |
| Restricted stock award and stock option expense amortization |   |         | — |   |   |   | — |                    |   |   | 1,068                                   |   |   |   | — |   |   |   | — |   |   |   | — |   |   |   | — |   |   |   | 1,068 |   |
| Stock options exercised and related tax benefits             |   |         | 15      |   |   |   | — |                    |   |   | 132                                     |   |   |   | — |   |   |   | — |   |   |   | — |   |   |   | — |   |   |   | 132 |   |
| Unrealized gain on hedging transaction, net                  |   |         | — |   |   |   | — |                    |   |   | —                                 |   |   |   | 106     |   |   |   | — |   |   |   | — |   |   |   | — |   |   |   | 106 |   |
| Secondary Offering                                           |   |         | 2,800   |   |   |   | 28      |                    |   |   | 19,034                                  |   |   |   | — |   |   |   | — |   |   |   | — |   |   |   | — |   |   |   | 19,062 |   |
| Retire Treasury Stock                                        |   |         | (84     | )      |   |   | (1      | )                       |   |   | (657                                    | )      |   |   | — |   |   |   | 84 |   |   |   | 657 |   |   |   | — |   |   |   | (1 | ) |
| Net income for the nine months endedSeptember 30, 2010       |   |         | — |   |   |   | — |                    |   |   | —                                 |   |   |   | — |   |   |   | — |   |   |   | — |   |   |   | 3,835 |   |   |   | 3,835 |   |
|  Balance at September 30, 2010                          |   |         | 11,731  |   |   | $      | 117     |                    |   | $      | 75,933                                  |   |   | $      | (82     | )      |   |   | (7 | ) |   | $ | (64 | ) |   | $ | 6,149 |   |   | $ | 82,053 |   |

----

|                                                                                         |   | For theThree-month periodEnded September 30, |   |   | For theNine-month periodEnded September 30, |   |
|----------------------------------------------------------------------------------------------|--------|----------------------------------------------|--------|--------|---------------------------------------------|--------|
|                                                                                         |   | 2010                                         |   |   | 2009                                        |   |   | 2010 |   |   | 2009 |   |
| Cash flows from operating activities:                                                        |   |                                         |   |   |                                        |   |   |   |   |   |   |   |
| Net income                                                                                   |   | $                                            | 1,099  |   |                                        | $      | 1,228 |   |   | $ | 3,835 |   |   | $ | 3,262 |   |
| Adjustments to reconcile net income to net cash provided by  operating activities: |   |                                         |   |   |                                        |   |   |   |   |   |   |   |   |   |   |   |
| Depreciation and amortization                                                                |   |                                         | 1,695  |   |                                        |   | 1,784 |   |   |   | 5,079 |   |   |   | 5,382 |   |
| Stock-based compensation                                                                     |   |                                         | 339    |   |                                        |   | 298 |   |   |   | 1,071 |   |   |   | 1,038 |   |
| Changes in assets and liabilities —                                                    |   |                                         |   |   |                                        |   |   |   |   |   |   |   |   |   |   |   |
| Decrease (increase) in assets                                                                |   |                                         |   |   |                                        |   |   |   |   |   |   |   |   |   |   |   |
| Patient and other accounts receivable                                                        |   |                                         | 835    |   |                                        |   | 56 |   |   |   | (440 | ) |   |   | (909 | ) |
| Other current assets                                                                         |   |                                         | (1,374 | )      |                                        |   | 395 |   |   |   | (1,937 | ) |   |   | 400 |   |
| Other assets                                                                                 |   |                                         | 203    |   |                                        |   | (408 | ) |   |   | 435 |   |   |   | (985 | ) |
| (Decrease) increase in liabilities                                                           |   |                                         |   |   |                                        |   |   |   |   |   |   |   |   |   |   |   |
| Accounts payable                                                                             |   |                                         | 630    |   |                                        |   | 185 |   |   |   | (7 | ) |   |   | (804 | ) |
| Accrued liabilities                                                                          |   |                                         | (1,029 | )      |                                        |   | 274 |   |   |   | 1,887 |   |   |   | 841 |   |
| Due to fertility medical practices                                                           |   |                                         | 531    |   |                                        |   | 410 |   |   |   | 6,018 |   |   |   | 4,197 |   |
| Deferred revenue and other patient deposits                                                  |   |                                         | 837    |   |                                        |   | 1,219 |   |   |   | 3,223 |   |   |   | 1,759 |   |
| Net cash provided by operating activities                                                    |   |                                         | 3,766  |   |                                        |   | 5,441 |   |   |   | 19,164 |   |   |   | 14,181 |   |
|                                                                                         |   |                                         |   |   |                                        |   |   |   |   |   |   |   |   |   |   |   |
| Cash flows from investing activities:                                                        |   |                                         |   |   |                                        |   |   |   |   |   |   |   |   |   |   |   |
| Purchase of fixed assets, net                                                                |   |                                         | (1,372 | )      |                                        |   | (806 | ) |   |   | (4,525 | ) |   |   | (4,466 | ) |
| Net cash used in investing activities                                                        |   |                                         | (1,372 | )      |                                        |   | (806 | ) |   |   | (4,525 | ) |   |   | (4,466 | ) |
|                                                                                         |   |                                         |   |   |                                        |   |   |   |   |   |   |   |   |   |   |   |
| Cash flows from financing activities:                                                        |   |                                         |   |   |                                        |   |   |   |   |   |   |   |   |   |   |   |
| Debt repayments                                                                              |   |                                         | (789   | )      |                                        |   | (914 | ) |   |   | (10,423 | ) |   |   | (2,835 | ) |
| Common Stock transactions, net                                                               |   |                                         | 79     |   |                                        |   | 11 |   |   |   | 19,092 |   |   |   | 31 |   |
| Net cash provided by (used in) financing activities                                          |   |                                         | (710   | )      |                                        |   | (903 | ) |   |   | 8,669 |   |   |   | (2,804 | ) |
|                                                                                         |   |                                         |   |   |                                        |   |   |   |   |   |   |   |   |   |   |   |
| Net increase in cash and cash equivalents                                                    |   |                                         | 1,684  |   |                                        |   | 3,732 |   |   |   | 23,308 |   |   |   | 6,911 |   |
| Cash and cash equivalents at beginning of period                                             |   |                                         | 50,489 |   |                                        |   | 31,454 |   |   |   | 28,865 |   |   |   | 28,275 |   |
| Cash and cash equivalents at end of period                                                   |   | $                                            | 52,173 |   |                                        | $      | 35,186 |   |   | $ | 52,173 |   |   | $ | 35,186 |   |
|                                                                                         |   |                                         |   |   |                                        |   |   |   |   |   |   |   |   |   |   |   |
| Supplemental Information:                                                                    |   |                                         |   |   |                                        |   |   |   |   |   |   |   |   |   |   |   |
| Interest paid                                                                                |   |                                         | 244    |   |                                        |   | 292 |   |   |   | 780 |   |   |   | 812 |   |
| Income taxes paid                                                                            |   |                                         | 1,127  |   |                                        |   | 65 |   |   |   | 2,172 |   |   |   | 3,658 |   |

----

|                                                                   |   | For the three-month periodEnded September 30, |   |   | For the nine-month periodEnded September 30, |   |
|------------------------------------------------------------------------|--------|-----------------------------------------------|--------|--------|----------------------------------------------|--------|
|                                                                   |   | 2010                                          |   |   | 2009                                         |   |   | 2010 |   |   | 2009 |   |
| Numerator                                                              |   |                                          |   |   |                                         |   |   |   |   |   |   |   |
|  Net Income                                                       |   | $                                             | 1,099  |   |                                         | $      | 1,228 |   |   | $ | 3,835 |   |   | $ | 3,262 |   |
|                                                                   |   |                                          |   |   |                                         |   |   |   |   |   |   |   |   |   |   |   |
| Denominator                                                            |   |                                          |   |   |                                         |   |   |   |   |   |   |   |   |   |   |   |
| Weighted average shares outstanding (basic)                            |   |                                          | 11,718 |   |                                         |   | 8,776 |   |   |   | 11,264 |   |   |   | 8,770 |   |
| Effect of dilutive options and warrants                                |   |                                          | 53     |   |                                         |   | 63 |   |   |   | 50 |   |   |   | 63 |   |
| Weighted average shares and dilutive potential Common shares (diluted) |   |                                          | 11,771 |   |                                         |   | 8,839 |   |   |   | 11,314 |   |   |   | 8,833 |   |
|                                                                   |   |                                          |   |   |                                         |   |   |   |   |   |   |   |   |   |   |   |
| Basic earnings per share                                               |   | $                                             | 0.09   |   |                                         | $      | 0.14 |   |   | $ | 0.34 |   |   | $ | 0.37 |   |
| Diluted earnings per share                                             |   | $                                             | 0.09   |   |                                         | $      | 0.14 |   |   | $ | 0.34 |   |   | $ | 0.37 |   |

----

|                                                        |   | Attain Fertility Centers |    |   | VeinClinics |   |   | Corp G&A |   |   | Consolidated |   |
|-------------------------------------------------------------|--------|--------------------------|---------|--------|-------------|--------|--------|--------------|--------|--------|--------------|--------|
|                                                        |   |                     |    |   |        |   |   |         |   |   |         |   |
| For the three months ended September 30, 2010               |   |                     |    |   |        |   |   |         |   |   |         |   |
|     Total Revenues, net                 |   | $                        | 45,899  |   |        | $      | 14,658 |         |   | $      | 0            |   |   | $ | 60,557 |   |
|     Cost of Services and Sales          |   |                     | 41,263  |   |        |   | 14,546 |         |   |   | 0            |   |   |   | 55,809 |   |
|     Contribution                        |   |                     | 4,636   |   |        |   | 112    |         |   |   | 0            |   |   |   | 4,748 |   |
|     Operating margin                    |   |                     | 10.1    | %      |        |   | 0.8    | %            |   |   | 0.0          | %      |   |   | 7.8 | % |
|                                                        |   |                     |    |   |        |   |   |         |   |   |         |   |   |   |   |   |
|     General and Administrative          |   |                     | 0       |   |        |   | 0      |         |   |   | 2,961        |   |   |   | 2,961 |   |
|     Interest (income) expense           |   |                     | (33     | )      |        |   | 0      |         |   |   | 192          |   |   |   | 159 |   |
|     Income before income taxes          |   | $                        | 4,669   |   |        | $      | 112    |         |   | $      | (3,153       | )      |   | $ | 1,628 |   |
|                                                        |   |                     |    |   |        |   |   |         |   |   |         |   |   |   |   |   |
|     Depreciation expense included above |   | $                        | 933     |   |        | $      | 287    |         |   | $      | 151          |   |   | $ | 1,371 |   |
|     Capital Expenditures                |   | $                        | 385     |   |        | $      | 820    |         |   | $      | 167          |   |   | $ | 1,372 |   |
|     Total Assets                        |   | $                        | 40,395  |   |        | $      | 52,402 |         |   | $      | 56,301       |   |   | $ | 149,098 |   |
|                                                        |   |                     |    |   |        |   |   |         |   |   |         |   |   |   |   |   |
| For the nine months ended September 30, 2010                |   |                     |    |   |        |   |   |         |   |   |         |   |   |   |   |   |
|     Total Revenues, net                 |   | $                        | 135,523 |   |        | $      | 43,826 |         |   | $      | 0            |   |   | $ | 179,349 |   |
|     Cost of Services and Sales          |   |                     | 122,053 |   |        |   | 40,891 |         |   |   | 0            |   |   |   | 162,944 |   |
|     Contribution                        |   |                     | 13,470  |   |        |   | 2,935  |         |   |   | 0            |   |   |   | 16,405 |   |
|     Operating margin                    |   |                     | 9.9     | %      |        |   | 6.7    | %            |   |   | 0.0          | %      |   |   | 9.1 | % |
|                                                        |   |                     |    |   |        |   |   |         |   |   |         |   |   |   |   |   |
|     General and Administrative          |   |                     | 0       |   |        |   | 0      |         |   |   | 9,403        |   |   |   | 9,403 |   |
|     Interest (income) expense           |   |                     | (103    | )      |        |   | 0      |         |   |   | 685          |   |   |   | 582 |   |
|     Income before income taxes          |   | $                        | 13,573  |   |        | $      | 2,935  |         |   | $      | (10,088      | )      |   | $ | 6,420 |   |
|                                                        |   |                     |    |   |        |   |   |         |   |   |         |   |   |   |   |   |
|     Depreciation expense included above |   | $                        | 2,833   |   |        | $      | 785    |         |   | $      | 490          |   |   | $ | 4,108 |   |
|     Capital Expenditures                |   | $                        | 2,105   |   |        | $      | 2,001  |         |   | $      | 419          |   |   | $ | 4,525 |   |
|     Total Assets                        |   | $                        | 40,395  |   |        | $      | 52,402 |         |   | $      | 56,301       |   |   | $ | 149,098 |   |

----

|                                                        |   | Attain Fertility Centers |    |   | VeinClinics |   |   | Corp G&A |   |   | Consolidated |   |
|-------------------------------------------------------------|--------|--------------------------|---------|--------|-------------|--------|--------|--------------|--------|--------|--------------|--------|
|                                                        |   |                     |    |   |        |   |   |         |   |   |         |   |
| For the three months ended September 30, 2009               |   |                     |    |   |        |   |   |         |   |   |         |   |
|    Total Revenues, net                            |   | $                        | 40,977  |   |        | $      | 12,621 |         |   | $      | 0            |   |   | $ | 53,598 |   |
|     Cost of Services and Sales          |   |                     | 36,930  |   |        |   | 11,626 |         |   |   | 0            |   |   |   | 48,556 |   |
|     Contribution                        |   |                     | 4,047   |   |        |   | 995    |         |   |   | 0            |   |   |   | 5,042 |   |
|     Operating margin                    |   |                     | 9.9     | %      |        |   | 7.9    | %            |   |   | 0.0          | %      |   |   | 9.4 | % |
|                                                        |   |                     |    |   |        |   |   |         |   |   |         |   |   |   |   |   |
|     General and Administrative          |   |                     |    |   |        |   |   |         |   |   | 2,764        |   |   |   | 2,764 |   |
|     Interest (income) expense           |   |                     | (44     | )      |        |   |   |         |   |   | 303          |   |   |   | 259 |   |
|     Income before income taxes          |   | $                        | 4,091   |   |        | $      | 995    |         |   | $      | (3,067       | )      |   | $ | 2,019 |   |
|                                                        |   |                     |    |   |        |   |   |         |   |   |         |   |   |   |   |   |
|     Depreciation expense included above |   | $                        | 1,018   |   |        | $      | 221    |         |   | $      | 222          |   |   | $ | 1,461 |   |
|     Capital Expenditures                |   | $                        | 364     |   |        | $      | 324    |         |   | $      | 121          |   |   | $ | 809 |   |
|     Total Assets                        |   | $                        | 35,897  |   |        | $      | 49,556 |         |   | $      | 43,003       |   |   | $ | 128,456 |   |
|                                                        |   |                     |    |   |        |   |   |         |   |   |         |   |   |   |   |   |
| For the nine months ended September 30, 2009                |   |                     |    |   |        |   |   |         |   |   |         |   |   |   |   |   |
|    Total Revenues, net                            |   | $                        | 124,780 |   |        | $      | 37,288 |         |   | $      | 0            |   |   | $ | 162,068 |   |
|     Cost of Services and Sales          |   |                     | 112,361 |   |        |   | 34,257 |         |   |   | 0            |   |   |   | 146,618 |   |
|     Contribution                        |   |                     | 12,419  |   |        |   | 3,031  |         |   |   | 0            |   |   |   | 15,450 |   |
|     Operating margin                    |   |                     | 10.0    | %      |        |   | 8.1    | %            |   |   | 0.0          | %      |   |   | 9.5 | % |
|                                                        |   |                     |    |   |        |   |   |         |   |   |         |   |   |   |   |   |
|     General and Administrative          |   |                     |    |   |        |   |   |         |   |   | 9,333        |   |   |   | 9,333 |   |
|     Interest (income) expense           |   |                     | (187    | )      |        |   |   |         |   |   | 869          |   |   |   | 682 |   |
|     Income before income taxes          |   | $                        | 12,606  |   |        | $      | 3,031  |         |   | $      | (10,202      | )      |   | $ | 5,435 |   |
|                                                        |   |                     |    |   |        |   |   |         |   |   |         |   |   |   |   |   |
|     Depreciation expense included above |   | $                        | 3,108   |   |        | $      | 640    |         |   | $      | 663          |   |   | $ | 4,411 |   |
|     Capital Expenditures                |   | $                        | 3,084   |   |        | $      | 705    |         |   | $      | 679          |   |   | $ | 4,468 |   |
|     Total Assets                        |   | $                        | 35,897  |   |        | $      | 49,556 |         |   | $      | 43,003       |   |   | $ | 128,456 |   |

----

|                                                            |   | AttainFertility Centers |   |   | VeinClinics |   |    | TotalCost of Services |   |
|-----------------------------------------------------------------|--------|-------------------------|--------|--------|-------------|--------|---------|-----------------------|--------|
|                                                            |   |                    |   |   |        |   |    |                  |   |
| For the three months ended September 30, 2010                   |   |                    |   |   |        |   |    |                  |   |
|      Employee Salaries & Benefits       |   | $                       | 23,118 |   |        | $      | 6,827   |                  |   | $ | 29,945 |   |
|      Professional Service Fees         |   |                    | 1,753  |   |        |   | — |                  |   |   | 1,753 |   |
|      Clinical Supplies & Donor Fee |   |                    | 3,881  |   |        |   | 1,439   |                  |   |   | 5,320 |    |
|      Office Expenses                   |   |                    | 1,485  |   |        |   | 768     |                  |   |   | 2,253 |   |
|      Occupancy Costs                   |   |                    | 3,339  |   |        |   | 653     |                  |   |   | 3,992 |   |
|      Depreciation/Lease Expense        |   |                    | 1,254  |   |        |   | 288     |                  |   |   | 1,542 |   |
|      Marketing and Promotion           |   |                    | 830    |   |        |   | 2,302   |                  |   |   | 3,132 |   |
|      Outside Services                  |   |                    | 941    |   |        |   | — |                  |   |   | 941 |   |
|      Insurance/Taxes                   |   |                    | 1,087  |   |        |   | 135     |                  |   |   | 1,222 |   |
|      Bad Debt                          |   |                    | 335    |   |        |   | 335     |                  |   |   | 670 |   |
|      Other                             |   |                    | 1,612  |   |        |   | 191     |                  |   |   | 1,803 |   |
|     Subtotal                                |   | $                       | 39,635 |   |        | $      | 12,938  |                  |   | $ | 52,573 |   |
|     Division Overhead                       |   |                    | 1,628  |   |        |   | 1,608   |                  |   |   | 3,236 |   |
|     Total Cost of Services and Sales        |   | $                       | 41,263 |   |        | $      | 14,546  |                  |   | $ | 55,809 |   |

|                                                            |   | AttainFertility Centers |   |   | VeinClinics |   |    | TotalCost of Services |   |
|-----------------------------------------------------------------|--------|-------------------------|--------|--------|-------------|--------|---------|-----------------------|--------|
|                                                            |   |                    |   |   |        |   |    |                  |   |
| For the three months ended September 30, 2009                   |   |                    |   |   |        |   |    |                  |   |
|      Employee Salaries & Benefits       |   | $                       | 17,002 |   |        | $      | 5,935   |                  |   | $ | 22,937 |   |
|      Professional Service Fees         |   |                    | 5,214  |   |        |   | — |                  |   |   | 5,214 |   |
|      Clinical Supplies & Donor Fee |   |                    | 3,136  |   |        |   | 1,301   |                  |   |   | 4,437 |   |
|      Office Expenses                   |   |                    | 940    |   |        |   | 409     |                  |   |   | 1,349 |   |
|      Occupancy Costs                   |   |                    | 3,060  |   |        |   | 464     |                  |   |   | 3,524 |   |
|      Depreciation/Lease Expense        |   |                    | 1,608  |   |        |   | 193     |                  |   |   | 1,801 |   |
|      Marketing and Promotion           |   |                    | 1,001  |   |        |   | 1,699   |                  |   |   | 2,700 |   |
|      Outside Services                  |   |                    | 851    |   |        |   | — |                  |   |   | 851 |   |
|      Insurance/Taxes                   |   |                    | 1,041  |   |        |   | 197     |                  |   |   | 1,238 |   |
|      Bad Debt                          |   |                    | 767    |   |        |   | 213     |                  |   |   | 980 |   |
|      Other                             |   |                    | 1,145  |   |        |   | 116     |                  |   |   | 1,261 |   |
|     Subtotal                                |   | $                       | 35,765 |   |        | $      | 10,527  |                  |   | $ | 46,292 |   |
|      Division Overhead                 |   |                    | 1,165  |   |        |   | 1,099   |                  |   |   | 2,264 |   |
|     Total Cost of Services and Sales        |   | $                       | 36,930 |   |        | $      | 11,626  |                  |   | $ | 48,556 |   |

----

|                                                      |   | AttainFertility Centers |    |   | VeinClinics |   |    | TotalCost of Services |   |
|-----------------------------------------------------------|--------|-------------------------|---------|--------|-------------|--------|---------|-----------------------|--------|
|                                                      |   |                    |    |   |        |   |    |                  |   |
| For the nine months ended September 30, 2010              |   |                    |    |   |        |   |    |                  |   |
|     Employee Salaries & Benefits       |   | $                       | 53,691  |   |        | $      | 20,261  |                  |   | $ | 73,952 |   |
|     Professional Service Fees         |   |                    | 19,701  |   |        |   | — |                  |   |   | 19,701 |   |
|     Clinical Supplies & Donor Fee |   |                    | 11,063  |   |        |   | 4,288   |                  |   |   | 15,351 |   |
|     Office Expenses                   |   |                    | 2,801   |   |        |   | 1,821   |                  |   |   | 4,622 |   |
|     Occupancy Costs                   |   |                    | 9,462   |   |        |   | 1,759   |                  |   |   | 11,221 |   |
|     Depreciation/Lease Expense        |   |                    | 4,439   |   |        |   | 620     |                  |   |   | 5,059 |   |
|     Marketing and Promotion           |   |                    | 2,763   |   |        |   | 5,591   |                  |   |   | 8,354 |   |
|     Outside Services                  |   |                    | 2,802   |   |        |   | — |                  |   |   | 2,802 |   |
|     Insurance/Taxes                   |   |                    | 3,269   |   |        |   | 375     |                  |   |   | 3,644 |   |
|     Bad Debt                          |   |                    | 1,487   |   |        |   | 1,244   |                  |   |   | 2,731 |   |
|     Other                             |   |                    | 5,922   |   |        |   | 193     |                  |   |   | 6,115 |   |
|     Subtotal                          |   | $                       | 117,400 |   |        | $      | 36,152  |                  |   | $ | 153,552 |   |
|     Division Overhead                 |   |                    | 4,653   |   |        |   | 4,739   |                  |   |   | 9,392 |   |
|     Total Cost of Services and Sales  |   | $                       | 122,053 |   |        | $      | 40,891  |                  |   | $ | 162,944 |   |

|                                                      |   | AttainFertility Centers |    |   | VeinClinics |   |    | TotalCost of Services |   |
|-----------------------------------------------------------|--------|-------------------------|---------|--------|-------------|--------|---------|-----------------------|--------|
|                                                      |   |                    |    |   |        |   |    |                  |   |
| For the nine months ended September 30, 2009              |   |                    |    |   |        |   |    |                  |   |
|     Employee Salaries & Benefits       |   | $                       | 51,490  |   |        | $      | 17,290  |                  |   | $ | 68,780 |   |
|     Professional Service Fees         |   |                    | 16,046  |   |        |   | — |                  |   |   | 16,046 |   |
|     Clinical Supplies & Donor Fee |   |                    | 9,799   |   |        |   | 3,506   |                  |   |   | 13,305 |   |
|     Office Expenses                   |   |                    | 2,908   |   |        |   | 1,345   |                  |   |   | 4,253 |   |
|     Occupancy Costs                   |   |                    | 9,222   |   |        |   | 1,383   |                  |   |   | 10,605 |   |
|     Depreciation/Lease Expense        |   |                    | 4,908   |   |        |   | 559     |                  |   |   | 5,467 |   |
|     Marketing and Promotion           |   |                    | 2,872   |   |        |   | 4,360   |                  |   |   | 7,232 |   |
|     Outside Services                  |   |                    | 2,696   |   |        |   | — |                  |   |   | 2,696 |   |
|     Insurance/Taxes                   |   |                    | 3,224   |   |        |   | 601     |                  |   |   | 3,825 |   |
|     Bad Debt                          |   |                    | 2,725   |   |        |   | 1,160   |                  |   |   | 3,885 |   |
|     Other                             |   |                    | 2,623   |   |        |   | 140     |                  |   |   | 2,763 |   |
|     Subtotal                          |   | $                       | 108,513 |   |        | $      | 30,344  |                  |   | $ | 138,857 |   |
|     Division Overhead                 |   |                    | 3,848   |   |        |   | 3,913   |                  |   |   | 7,761 |   |
|     Total Cost of Services and Sales  |   | $                       | 112,361 |   |        | $      | 34,257  |                  |   | $ | 146,618 |   |

----

|                            |   | September 30, |   | December 31, |   |
|---------------------------------|--------|---------------|--------|--------------|--------|
|                            |   | 2010          |   | 2009         |   |
|                            |   | (unaudited)   |   |         |   |
|  Cash                      |   | $             | 34,059 |         |   | $ | 15,770 |   |
| Short term investments          |   |          | 18,114 |         |   |   | 13,081 |   |
| Accrued interest income         |   |          |   |         |   |   | 14 |   |
| Total cash and cash equivalents |   | $             | 52,173 |         |   | $ | 28,865 |   |

|                                          | September 30, |   | December 31, |   |
|-----------------------------------------------|---------------|--------|--------------|--------|
|                                          | 2010          |   | 2009         |   |
|                                          | (unaudited)   |   |         |   |
| Vein Clinic patient and insurance receivables |          | $      | 9,795        |   |   | $ | 9,773 |   |
| Reserve for uncollectible accounts            |          |   | (2,439       | )      |   |   | (2,913 | ) |
| Subtotal Vein Clinic receivables, net         |          | $      | 7,356        |   |   | $ | 6,860 |   |
| Other receivables                             |          |   | 48           |   |   |   | 104 |   |
| Total Patient and other receivables, net      |          | $      | 7,404        |   |   | $ | 6,964 |   |

----

|                                    |  September 30, |   | December 31, |   |
|-----------------------------------------|---------------------|--------|--------------|--------|
|                                    | 2010                |   | 2009         |   |
|                                    | (unaudited)         |   |         |   |
| Advances to Medical Practices           |                | $      | (15,835      | )      |   | $ | (14,653 | ) |
| Undistributed Physician Earnings        |                |   | 4,110        |   |   |   | 2,270 |   |
| Physician Practice Patient Deposits     |                |   | 24,167       |   |   |   | 18,807 |   |
| Due to Fertility Medical Practices, net |                | $      | 12,442       |   |   | $ | 6,424 |   |

----

|                                          |   | September 30, |   |   | December 31, |   |
|-----------------------------------------------|--------|---------------|--------|--------|--------------|--------|
|                                          |   | 2010          |   |   | 2009         |   |
|                                          |   | (unaudited)   |   |   |         |   |
| Term Loans                                    |   | $             | 15,368 |   |         | $      | 18,142 |   |
| Revolving Line of Credit                      |   |          | -      |   |         |   | 7,500 |   |
| Derivative Fair valuation adjustment          |   |          | 129    |   |         |   | 306 |   |
| Obligations under capital leases              |   |          | 152    |   |         |   | 218 |   |
|                                          |   |          |   |   |         |   |   |   |
| Total notes payable and other obligations     |   | $             | 15,649 |   |         | $      | 26,166 |   |
| Less — current portion                  |   |          | (3,791 | )      |         |   | (11,317 | ) |
|                                          |   |          |   |   |         |   |   |   |
| Long-term notes payable and other obligations |   | $             | 11,858 |   |         | $      | 14,849 |   |

----

|                          |   | For the three-month periodEnded September 30, |   | For the nine-month periodEnded September 30, |
|-------------------------------|--------|-----------------------------------------------|--------|----------------------------------------------|
|                          |   | 2010                                          |   | 2009                                         |   | 2010 |   | 2009 |
| Fair value of options granted |   | $                                             | 4.96   |                                         | N/A |   | $ | 5.11 |   | N/A |
| Dividend yield                |   |                                          | 0%     |                                         | N/A |   |   | 0% |   | N/A |
| Expected volatility           |   |                                          | 48.4%  |                                         | N/A |   |   | 57.4% |   | N/A |
| Risk free interest rate       |   |                                          | 2.5%   |                                         | N/A |   |   | 3.9% |   | N/A |
| Expected term in years        |   |                                          | 5.0    |                                         | N/A |   |   | 5.0 |   | N/A |

|                                      |  Number of shares of Common Stock underlying options |   | Weighted Average Exercise Price |   |
|-------------------------------------------|-----------------------------------------------------------|--------|---------------------------------|--------|
| Options outstanding at December 31, 2009  | 205,685                                                   |   | $                               | 5.78   |   |
| Granted – stock options             | 81,117                                                    |   | $                               | 7.97   |   |
| Granted – stock awards              | 168,347                                                   |   | $                               | 7.96   |   |
| Exercised – stock options           | 15,439                                                    |   | $                               | 1.91   |   |
| Exercised – stock awards            | 168,347                                                   |   | $                               | 7.96   |   |
| Canceled                                  | —                                                   |   |                            |   |   |
|                                      |                                                      |   |                            |   |   |
| Options outstanding at September 30, 2010 | 271,363                                                   |   | $                               | 6.97   |   |
|                                      |                                                      |   |                            |   |   |
| Options exercisable at:                   |                                                      |   |                            |   |   |
| December 31, 2009                         | 119,771                                                   |   | $                               | 4.64   |   |
| September 30, 2010                        | 128,301                                                   |   | $                               | 5.68   |   |

----

|                                               |   | For the three-month periodEnded September 30, |   |   | For the nine-month periodEnded September 30, |   |
|----------------------------------------------------|--------|-----------------------------------------------|--------|--------|----------------------------------------------|--------|
|                                               |   | 2010                                          |   |   | 2009                                         |   |   | 2010 |   |   | 2009 |   |
| Net income as reported                             |   | $                                             | 1,099  |   |                                         | $      | 1,228 |   |   | $ | 3,835 |   |   | $ | 3,262 |   |
| Unrealized gain (loss) on hedging transaction, net |   |                                          | (23    | )      |                                         |   | 71 |   |   |   | 106 |   |   |   | 153 |   |
|                                               |   |                                          |   |   |                                         |   |   |   |   |   |   |   |   |   |   |   |
| Total comprehensive income                         |   | $                                             | 1,076  |   |                                         | $      | 1,299 |   |   | $ | 3,941 |   |   | $ | 3,415 |   |

----

----

|          |                                                                                                     |
|---------------|----------------------------------------------------------------------------------------------------------|
| •  | Drive growth at our contracted fertility centers by providing additional management; services.      |
|          |                                                                                                     |
| •  | Expand the relationships to additional fertility centers through the sale of consumer product offerings; |
|          |                                                                                                     |
| •  | Developing de novo vein clinics;                                                                         |
|          |                                                                                                     |
| •  | Increasing the total number of patients treated;                                                         |
|          |                                                                                                     |
| •  | Increasing the penetration of our Attain IVF programs; and                                          |
|          |                                                                                                     |
| •  | Continuing to improve operating efficiencies.                                                            |

----

----

----

|                                |   | For the three-month periodEnded September 30, |   | For the nine-month periodEnded September 30, |   |
|-------------------------------------|--------|-----------------------------------------------|--------|----------------------------------------------|--------|
|                                |   | 2010                                          |   | 2009                                         |   | 2010 |   | 2009 |   |
| Revenues, Net                       |   |                                          |   |                                         |   |   |   |   |   |   |
| Attain Fertility Centers            |   |                                          | 75.8   | %                                            | 76.5   | % | 75.6 | % | 77.0 | % |
| Vein Clinics                        |   |                                          | 24.2   | %                                            | 23.5   | % | 24.4 | % | 23.0 | % |
| Total revenues                      |   |                                          | 100.0  | %                                            | 100.0  | % | 100.0 | % | 100.0 | % |
|                                |   |                                          |   |                                         |   |   |   |   |   |   |
| Cost of services and sales          |   |                                          |   |                                         |   |   |   |   |   |   |
| Attain Fertility Centers            |   |                                          | 68.1   | %                                            | 68.9   | % | 68.1 | % | 69.3 | % |
| Vein Clinics                        |   |                                          | 24.0   | %                                            | 21.7   | % | 22.8 | % | 21.1 | % |
| Total cost of services and sales    |   |                                          | 92.2   | %                                            | 90.6   | % | 90.9 | % | 90.5 | % |
|                                |   |                                          |   |                                         |   |   |   |   |   |   |
| Contribution                        |   |                                          |   |                                         |   |   |   |   |   |   |
| Attain Fertility Centers            |   |                                          | 7.7    | %                                            | 7.6    | % | 7.5 | % | 7.7 | % |
| Vein Clinics                        |   |                                          | 0.2    | %                                            | 1.9    | % | 1.6 | % | 1.9 | % |
| Total contributions                 |   |                                          | 7.8    | %                                            | 9.4    | % | 9.1 | % | 9.5 | % |
|                                |   |                                          |   |                                         |   |   |   |   |   |   |
| General and administrative expenses |   |                                          | 4.9    | %                                            | 5.2    | % | 5.2 | % | 5.8 | % |
| Interest income                     |   |                                          | (0.1)  | %                                            | (0.1)  | % | (0.1) | % | (0.1) | % |
| Interest expense                    |   |                                          | 0.3    | %                                            | 0.6    | % | 0.4 | % | 0.5 | % |
| Total other expenses                |   |                                          | 5.2    | %                                            | 5.6    | % | 5.5 | % | 6.2 | % |
|                                |   |                                          |   |                                         |   |   |   |   |   |   |
| Income before income taxes          |   |                                          | 2.7    | %                                            | 3.8    | % | 3.6 | % | 3.4 | % |
| Income tax provision                |   |                                          | 0.9    | %                                            | 1.5    | % | 1.4 | % | 1.3 | % |
| Net income                          |   |                                          | 1.8    | %                                            | 2.3    | % | 2.2 | % | 2.0 | % |

----

|                           |   |   | Q3 2010 |   |   |   | Q3 2009 |   |   | Change |   |   | % Change |   |   | YTD 2010 |   |   | YTD 2009 |   |   | Change |    |   | % Change |   |
|--------------------------------|--------|--------|---------|--------|--------|--------|---------|--------|--------|--------|--------|--------|----------|--------|--------|----------|--------|--------|----------|--------|--------|--------|---------|--------|----------|--------|
| Revenues (000’s)         |   | $      | 45,899  |   |   | $      | 40,977  |   |   | $      | 4,922  |   |     |   | 12.0   | %        |   | $      | 135,523  |   |   | $      | 124,780 |   |     | $      | 10,743 |   |   |   | 8.6 | % |
| Operating Income (000’s) |   | $      | 4,636   |   |   | $      | 4,047   |   |   | $      | 589    |   |     |   | 14.6   | %        |   | $      | 13,470   |   |   | $      | 12,419  |   |     | $      | 1,051 |   |   |   | 8.5 | % |
| Partner Centers Statistics     |   |   |    |   |   |   |    |   |   |   |   |   |     |   |   |     |   |   |     |   |   |   |    |   |     |   |   |   |   |   |   |   |
| New Patient Visits             |   |   | 6,933   |   |   |   | 7,069   |   |   |   | (136   | )      |     |   | (1.9   | %)       |   |   | 20,949   |   |   |   | 21,135  |   |     |   | (186 | ) |   |   | (0.9 | %) |
| IVF Cycles                     |   |   | 3,578   |   |   |   | 3,488   |   |   |   | 90     |   |     |   | 2.6    | %        |   |   | 10,470   |   |   |   | 10,672  |   |     |   | (202 | ) |   |   | (1.9 | %) |
| IUI Cycles                     |   |   | 6,103   |   |   |   | 6,065   |   |   |   | 38     |   |     |   | 0.6    | %        |   |   | 17,930   |   |   |   | 17,821  |   |     |   | 109 |   |   |   | 0.6 | % |
| Attain Statistics              |   |   |    |   |   |   |    |   |   |   |   |   |     |   |   |     |   |   |     |   |   |   |    |   |     |   |   |   |   |   |   |   |
| Applications                   |   |   | 713     |   |   |   | 552     |   |   |   | 161    |   |     |   | 29.2   | %        |   |   | 2,237    |   |   |   | 1,620   |   |     |   | 617 |   |   |   | 38.1 | % |
| Enrollments                    |   |   | 448     |   |   |   | 288     |   |   |   | 160    |   |     |   | 55.6   | %        |   |   | 1,242    |   |   |   | 780     |   |     |   | 462 |   |   |   | 59.2 | % |
| Pregnancies                    |   |   | 711     |   |   |   | 420     |   |   |   | 291    |   |     |   | 69.3   | %        |   |   | 755      |   |   |   | 585     |   |     |   | 170 |   |   |   | 29.1 | % |

| ·   | A base service fee calculated as a percentage of patient revenue as reported by the center (this percentage varies from 6% down to 3% depending on the agreement and the level of patient revenues); |
|--------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | Cost of services equal to reimbursement for the expenses which we advanced to the center during the month (representing substantially all of the expenses incurred by the practice, except physician compensation); and |
|--------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | Our additional fees which represent our share of the net income of the center (which varies from 10% to 20% or a fixed amount depending on the underlying center, subject to limits in some circumstances). |
|--------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|                                                      |   | For the three-month periodEnded September 30, |   |   | For the nine-month periodEnded September 30, |   |
|-----------------------------------------------------------|--------|-----------------------------------------------|--------|--------|----------------------------------------------|--------|
|                                                      |   | 2010                                          |   |   | 2009                                         |   |   | 2010 |   |   | 2009 |   |
|                                                      |   | (unaudited)                                   |   |   | (unaudited)                                  |   |
| Physician Financials                                      |   |                                          |   |   |                                         |   |   |   |   |   |   |   |
| (a) Patient revenue                                       |   | $                                             | 54,102 |   |                                         | $      | 49,478 |   |   | $ | 160,993 |   |   | $ | 149,365 |   |
| (b) Cost of services                                      |   |                                          | 34,334 |   |                                         |   | 32,319 |   |   |   | 103,221 |   |   |   | 98,603 |   |
| (c) Base service fee                                      |   |                                          | 2,730  |   |                                         |   | 2,319 |   |   |   | 8,176 |   |   |   | 7,005 |   |
| (d) Practice contribution (a-b-c)                         |   |                                          | 17,038 |   |                                         |   | 14,840 |   |   |   | 49,596 |   |   |   | 43,757 |   |
| (e) Additional service fee                                |   |                                          | 1,416  |   |                                         |   | 1,617 |   |   |   | 4,278 |   |   |   | 4,814 |   |
| (f) Contribution retained by the Physician Partners (d-e) |   |                                          | 15,622 |   |                                         |   | 13,223 |   |   |   | 45,318 |   |   |   | 38,943 |   |
|                                                      |   |                                          |   |   |                                         |   |   |   |   |   |   |   |   |   |   |   |
| IntegraMed Fertility Center Financials                    |   |                                          |   |   |                                         |   |   |   |   |   |   |   |   |   |   |   |
| (g) IntegraMed gross revenue from Partner clinics (b+c+e) |   |                                          | 38,480 |   |                                         |   | 36,255 |   |   |   | 115,675 |   |   |   | 110,422 |   |
| (h) Amortization of business service rights               |   |                                          | (324   | )      |                                         |   | (324 | ) |   |   | (972 | ) |   |   | (972 | ) |
| (i) Other Revenue                                         |   |                                          | 75     |   |                                         |   | 33 |   |   |   | 106 |   |   |   | 88 |   |
| (j) Total Fertility Centers Revenue                       |   |                                          | 38,231 |   |                                         |   | 35,964 |   |   |   | 114,809 |   |   |   | 109,538 |   |
| (k) Cost of Services                                      |   |                                          | 35,211 |   |                                         |   | 32,985 |   |   |   | 105,722 |   |   |   | 100,860 |   |
| (l) Contribution of IntegraMed Fertility Centers (j-k)    |   | $                                             | 3,020  |   |                                         | $      | 2,979 |   |   | $ | 9,087 |   |   | $ | 8,678 |   |

| ·   | The number of patients enrolled and receiving treatment; and |
|--------------------|--------------------------------------------------------------|

| ·   | Clinical pregnancy rates |
|--------------------|--------------------------|

----

|                           |   |   | Q3 2010 |   |   |   | Q3 2009 |   |   | Change |   |   | % Change |   |   | YTD 2010 |   |   | YTD 2009 |   |   | Change |   |   | % Change |   |
|--------------------------------|--------|--------|---------|--------|--------|--------|---------|--------|--------|--------|--------|--------|----------|--------|--------|----------|--------|--------|----------|--------|--------|--------|--------|--------|----------|--------|
| Revenues (000’s)         |   | $      | 14,658  |   |   | $      | 12,621  |   |   | $      | 2,037  |   |     |   | 16.1   | %        |   | $      | 43,826   |   |   | $      | 37,288 |   |     | $      | 6,538 |   |   |   | 17.5 | % |
| Operating Income (000’s) |   | $      | 112     |   |   | $      | 995     |   |   | $      | (883   | )      |     |   | (88.7  | %)       |   | $      | 2,935    |   |   | $      | 3,031  |   |     | $      | (96 | ) |   |   | (3.2 | %) |
| Inquiries                      |   |   | 5,231   |   |   |   | 5,317   |   |   |   | (86    | )      |     |   | (1.6   | %)       |   |   | 17,849   |   |   |   | 16,968 |   |     |   | 881 |   |   |   | 5.2 | % |
| New Consultations              |   |   | 3,781   |   |   |   | 3,896   |   |   |   | (115   | )      |     |   | (3.0   | %)       |   |   | 11,848   |   |   |   | 11,600 |   |     |   | 248 |   |   |   | 2.1 | % |
| First Leg Starts               |   |   | 2,097   |   |   |   | 1,963   |   |   |   | 134    |   |     |   | 6.8    | %        |   |   | 6,379    |   |   |   | 5,618  |   |     |   | 761 |   |   |   | 13.5 | % |

----

----

----

|                               |   | Payments due by period (000’s omitted) |   |
|------------------------------------|--------|----------------------------------------------|--------|
|                               |   | Total                                        |   |   | Less than 1 Year |   |   | 1-3 Years |   |   | 4-5 Years |   |   | After 5 Years |   |
|                               |   |                                         |   |
| Notes payable                      |   | $                                            | 15,497 |   |   | $ | 3,697 |   |   | $ | 11,800 |   |   | $ | — |   |   | $ | — |   |
|                               |   |                                         |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Capital lease obligations          |   |                                         | 152    |   |   |   | 94 |   |   |   | 58 |   |   |   | — |   |   |   | — |   |
| Interest on debt                   |   |                                         | 1,471  |   |   |   | 729 |   |   |   | 742 |   |   |   | — |   |   |   | — |   |
| Operating leases                   |   |                                         | 70,661 |   |   |   | 2,050 |   |   |   | 31,994 |   |   |   | 7,960 |   |   |   | 28,657 |   |
| Total contractual cash obligations |   | $                                            | 87,781 |   |   | $ | 6,570 |   |   | $ | 44,594 |   |   | $ | 7,960 |   |   | $ | 28,657 |   |

----

|                   |   | Amount of Commitment Expiration per Period(000’s omitted) |   |
|------------------------|--------|-----------------------------------------------------------------|--------|
|                   |   | Total                                                           |   |   | Less than 1 Year |   |   | 1-3 Years |   |   | 4-5 Years |   |   | After 5 Years |   |
|                   |   |                                                            |   |
| Unused lines of credit |   | $                                                               | 35,000 |   |   | $ | — |   |   | $ | 35,000 |   |   | $ | — |   |   | $ | — |   |

| ·   | We provide a cash credit to the practice for billings to patients and insurance companies;. |
|--------------------|---------------------------------------------------------------------------------------------|

| ·   | We reduce the cash credit for clinic expenses that we have incurred on behalf of the practice; |
|--------------------|------------------------------------------------------------------------------------------------|

| ·   | We reduce the cash credit for the base portion of our Service Fee which relates to the practice revenues; |
|--------------------|-----------------------------------------------------------------------------------------------------------|

| ·   | We reduce the cash credit for the variable portion of our Service Fee which relates to the practice earnings; |
|--------------------|---------------------------------------------------------------------------------------------------------------|

| ·   | We disburse to the medical practice the remaining cash amount which represents the physician's undistributed earnings. |
|--------------------|------------------------------------------------------------------------------------------------------------------------|

----

| (a)   | Evaluation of disclosure controls and procedures |
|-----------------|--------------------------------------------------|

----

| Part II         |   |  OTHER INFORMATION                                                                                                                                                                                                                                                    |
|----------------------|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                 |   |                                                                                                                                                                                                                                                                       |
|                 |   |                                                                                                                                                                                                                                                                       |
|  Item 1.   |   |  Legal Proceedings                                                                                                                                                                                                                                                    |
|                 |   |                                                                                                                                                                                                                                                                       |
|                 |   |  From time to time, we are party to legal proceedings in the ordinary course of business.  As of September 30, 2010, none of these proceedings is expected to have a material adverse effect on our financial position, results of operations or cash flow. |
|                 |   |                                                                                                                                                                                                                                                                       |
|  Item 1A.  |   |  Risk Factors                                                                                                                                                                                                                                                         |
|                 |   |                                                                                                                                                                                                                                                                       |
|                 |   |  There have been no material changes from the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2009.                                                                                                               |
|                 |   |                                                                                                                                                                                                                                                                       |
| Item 2.              |   | Unregistered Sales of Equity Securities and Use of Proceeds                                                                                                                                                                                                                |
|                 |   |  None.                                                                                                                                                                                                                                                                |
|                 |   |                                                                                                                                                                                                                                                                       |
| Item 3.              |   | Defaults upon Senior Securities                                                                                                                                                                                                                                            |
|                 |   |                                                                                                                                                                                                                                                                       |
|                 |   |  None.                                                                                                                                                                                                                                                                |
|                 |   |                                                                                                                                                                                                                                                                       |
| Item 4.              |   | (Removed and Reserved)                                                                                                                                                                                                                                                     |   |
|                 |   |                                                                                                                                                                                                                                                                       |   |
|                 |   |                                                                                                                                                                                                                                                                       |   |
| Item 5.              |   | Other Information                                                                                                                                                                                                                                                          |   |
|                 |   |                                                                                                                                                                                                                                                                       |   |
|                 |   | None.                                                                                                                                                                                                                                                                      |   |
|                 |   |                                                                                                                                                                                                                                                                       |   |
| Item 5.              |   | Exhibits                                                                                                                                                                                                                                                                   |   |
|                 |   |                                                                                                                                                                                                                                                                       |   |
|                 |   | See Index to Exhibits on Page 32.                                                                                                                                                                                                                                          |   |
|                 |   |                                                                                                                                                                                                                                                                       |   |

----

|       |                   |   |   |                                                                                                              |
|------------|------------------------|--------|--------|-------------------------------------------------------------------------------------------------------------------|
|  Date |  November 9, 2010 |   | By:    | INTEGRAMED AMERICA, INC.(Registrant)  /s/   John W. Hlywak, Jr.                               |
|       |                   |   |   | John W. Hlywak, Jr.Executive Vice President andChief Financial Officer(Principal Financial andAccounting Officer) |

----

| ExhibitNumber | Description                                                                                                                                                                                |
|---------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|          |                                                                                                                                                                                       |
|          |                                                                                                                                                                                       |
| 10.65         | Amendment No. 7, dated October 12, 2010, to Service Agreement Between IntegraMed America, Inc. and Reproductive Science Center of the San Francisco Bay Area, a Medical Corporation.  |
| 31.1          | CEO Certification Pursuant to Rule 13a-14(a) as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 dated November 9, 2010                                                   |
|          |                                                                                                                                                                                       |
| 31.2          | CFO Certification Pursuant to Rule 13a-14(a) as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 dated November 9, 2010                                                   |
|          |                                                                                                                                                                                       |
| 32.1          | CEO Certification Pursuant to 18 U.S.C. § 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 dated November 9, 2010                                            |
|          |                                                                                                                                                                                       |
| 32.2          | CFO Certification Pursuant to 18 U.S.C. § 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 dated November 9, 2010                                            |

----